CD30 - Governor of memory T cells?

被引:31
作者
Podack, ER [1 ]
Strbo, N [1 ]
Sotosec, V [1 ]
Muta, H [1 ]
机构
[1] Univ Miami, Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA
来源
MICROARRAYS, IMMUNE RESPONSES AND VACCINES | 2002年 / 975卷
关键词
CD30; memory T-cells; T regulatory cells;
D O I
10.1111/j.1749-6632.2002.tb05945.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD30 is well recognized as a marker expressed by a heterogeneous group of lymphomas and in several immune and autoimmune disorders. However, the function of CD30 in theses diseases or in the normal immune response has remained unclear. Studying gene expression patterns induced by stimulating CD30 signals on a large granular lymphoma cell line, YT, with an agonistic anti-CD30 antibody, we found that CD30 signals affected proapoptotic and antiapoptotic genes, regulated cytotoxicity, and controlled molecules regulating T cell traffic. Creating CD30-L deficient mice and studying CD8 CTL activation and memory responses, it was observed that the absence of CD30-L resulted in diminished primary clonal expansion of CD8 cells. In addition the absence of CD30-L abolished clonal contraction after primary expansion and interfered with secondary expansion upon boosting. The studies suggest that CD30 regulates CD8 CTL function and survival during memory responses and is important for clonal contraction.
引用
收藏
页码:101 / 113
页数:13
相关论文
共 35 条
[1]  
ALZONA M, 1994, J IMMUNOL, V153, P2861
[2]   Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice [J].
Amakawa, R ;
Hakem, A ;
Kundig, TM ;
Matsuyama, T ;
Simard, JJL ;
Timms, E ;
Wakeham, A ;
Mittruecker, HW ;
Griesser, H ;
Takimoto, H ;
Schmits, R ;
Shahinian, A ;
Ohashi, PS ;
Penninger, JM ;
Mak, TW .
CELL, 1996, 84 (04) :551-562
[3]   RETRACTED: Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation (Retracted article. See vol 94, pg 12732, 1997) [J].
Ansieau, S ;
Scheffrahn, I ;
Mosialos, G ;
Brand, H ;
Duyster, J ;
Kaye, K ;
Harada, J ;
Dougall, B ;
Hubinger, G ;
Kieff, E ;
Herrmann, F ;
Leutz, A ;
Gruss, HJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (24) :14053-14058
[4]   Translocation of TRAF proteins regulates apoptotic threshold of cells [J].
Arch, RH ;
Gedrich, RW ;
Thompson, CB .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 272 (03) :936-945
[5]   The CCR7 ligand ELC (CCL19) is transcytosed in high endothelial venules and mediates T cell recruitment [J].
Baekkevold, ES ;
Yamanaka, T ;
Palframan, RT ;
Carlsen, HS ;
Reinholt, FP ;
von Andrian, UH ;
Brandtzaeg, P ;
Haraldsen, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (09) :1105-1111
[6]  
BOWEN MA, 1993, J IMMUNOL, V151, P5896
[7]  
Bowen MA, 1996, J IMMUNOL, V156, P442
[8]   CD30 is a CD40-inducible molecule that negatively regulates CD40-mediated immunoglobulin class switching in non-antigen-selected human B cells [J].
Cerutti, A ;
Schaffer, A ;
Shah, S ;
Zan, H ;
Liou, HC ;
Goodwin, RG ;
Casali, P .
IMMUNITY, 1998, 9 (02) :247-256
[9]   Dysregulation of CD30+ T cells by leukemia impairs isotype switching in normal B cells [J].
Cerutti, A ;
Kim, EC ;
Shah, S ;
Schattner, EJ ;
Zan, H ;
Schaffer, A ;
Casali, P .
NATURE IMMUNOLOGY, 2001, 2 (02) :150-156
[10]   Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+ IgM+ B cells [J].
Cerutti, A ;
Schaffer, A ;
Goodwin, RG ;
Shah, S ;
Zan, H ;
Ely, S ;
Casali, P .
JOURNAL OF IMMUNOLOGY, 2000, 165 (02) :786-794